DOI:
10.1055/s-00034917
Kinder- und Jugendmedizin
LinksClose Window
References
Detert J, Bastian H, Listing J. et al.
Induction therapy with adalimumab plus methotrexate for 24 weeks followed by methotrexate monotherapy up to week 48 versus methotrexate therapy alone for DMARD-naive patients with early rheumatoid arthritis: HIT HARD, an investigator-initiated study.
Annals of the rheumatic diseases 2013;
72: 844-850.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.